Industry Research Reports

Home > Reports > Service & Software > Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global AI Drug Development Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 95 Pages

Report ld: 4026083

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global AI Drug Development market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global AI Drug Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global AI Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI
Lam Therapeutics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Drug Design
Drug Synthesis
Other

Segment by Application

Tumor
Nervous System
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of AI Drug Development in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of AI Drug Development manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Development revenue, gross margin, and recent development, etc.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Drug Design

1.2.3 Drug Synthesis

1.2.4 Other

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Tumor

1.3.3 Nervous System

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI Drug Development Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global AI Drug Development Revenue Market Share by Region (2020-2025)

2.4 Global AI Drug Development Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America AI Drug Development Market Size and Prospective (2020-2031)

2.5.2 Europe AI Drug Development Market Size and Prospective (2020-2031)

2.5.3 China AI Drug Development Market Size and Prospective (2020-2031)

2.5.4 Japan AI Drug Development Market Size and Prospective (2020-2031)

2.5.5 Southeast Asia AI Drug Development Market Size and Prospective (2020-2031)

2.5.6 India AI Drug Development Market Size and Prospective (2020-2031)

2.5.7 Central & South America AI Drug Development Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global AI Drug Development Historic Market Size by Type (2020-2025)

3.2 Global AI Drug Development Forecasted Market Size by Type (2026-2031)

3.3 Different Types AI Drug Development Representative Players

4 Breakdown Data by Application

4.1 Global AI Drug Development Historic Market Size by Application (2020-2025)

4.2 Global AI Drug Development Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in AI Drug Development Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top AI Drug Development Players by Revenue (2020-2025)

5.1.2 Global AI Drug Development Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by AI Drug Development Revenue

5.4 Global AI Drug Development Market Concentration Analysis

5.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2024

5.5 Global Key Players of AI Drug Development Head office and Area Served

5.6 Global Key Players of AI Drug Development, Product and Application

5.7 Global Key Players of AI Drug Development, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America AI Drug Development Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America AI Drug Development Market Size by Type (2020-2025)

6.1.2.2 North America AI Drug Development Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America AI Drug Development Market Size by Application (2020-2025)

6.1.3.2 North America AI Drug Development Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe AI Drug Development Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe AI Drug Development Market Size by Type (2020-2025)

6.2.2.2 Europe AI Drug Development Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe AI Drug Development Market Size by Application (2020-2025)

6.2.3.2 Europe AI Drug Development Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China AI Drug Development Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China AI Drug Development Market Size by Type (2020-2025)

6.3.2.2 China AI Drug Development Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China AI Drug Development Market Size by Application (2020-2025)

6.3.3.2 China AI Drug Development Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan AI Drug Development Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan AI Drug Development Market Size by Type (2020-2025)

6.4.2.2 Japan AI Drug Development Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan AI Drug Development Market Size by Application (2020-2025)

6.4.3.2 Japan AI Drug Development Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 Southeast Asia Market: Players, Segments and Downstream

6.5.1 Southeast Asia AI Drug Development Revenue by Company (2020-2025)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia AI Drug Development Market Size by Type (2020-2025)

6.5.2.2 Southeast Asia AI Drug Development Market Share by Type (2020-2025)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia AI Drug Development Market Size by Application (2020-2025)

6.5.3.2 Southeast Asia AI Drug Development Market Share by Application (2020-2025)

6.5.4 Southeast Asia Market Trend and Opportunities

6.6 India Market: Players, Segments and Downstream

6.6.1 India AI Drug Development Revenue by Company (2020-2025)

6.6.2 India Market Size by Type

6.6.2.1 India AI Drug Development Market Size by Type (2020-2025)

6.6.2.2 India AI Drug Development Market Share by Type (2020-2025)

6.6.3 India Market Size by Application

6.6.3.1 India AI Drug Development Market Size by Application (2020-2025)

6.6.3.2 India AI Drug Development Market Share by Application (2020-2025)

6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Insilico Medicine

7.1.1 Insilico Medicine Company Details

7.1.2 Insilico Medicine Business Overview

7.1.3 Insilico Medicine AI Drug Development Introduction

7.1.4 Insilico Medicine Revenue in AI Drug Development Business (2020-2025)

7.1.5 Insilico Medicine Recent Development

7.2 Cyclica

7.2.1 Cyclica Company Details

7.2.2 Cyclica Business Overview

7.2.3 Cyclica AI Drug Development Introduction

7.2.4 Cyclica Revenue in AI Drug Development Business (2020-2025)

7.2.5 Cyclica Recent Development

7.3 XtalPi Inc.

7.3.1 XtalPi Inc. Company Details

7.3.2 XtalPi Inc. Business Overview

7.3.3 XtalPi Inc. AI Drug Development Introduction

7.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2020-2025)

7.3.5 XtalPi Inc. Recent Development

7.4 Exscientia Limited

7.4.1 Exscientia Limited Company Details

7.4.2 Exscientia Limited Business Overview

7.4.3 Exscientia Limited AI Drug Development Introduction

7.4.4 Exscientia Limited Revenue in AI Drug Development Business (2020-2025)

7.4.5 Exscientia Limited Recent Development

7.5 AiCure, LLC

7.5.1 AiCure, LLC Company Details

7.5.2 AiCure, LLC Business Overview

7.5.3 AiCure, LLC AI Drug Development Introduction

7.5.4 AiCure, LLC Revenue in AI Drug Development Business (2020-2025)

7.5.5 AiCure, LLC Recent Development

7.6 Atomwise

7.6.1 Atomwise Company Details

7.6.2 Atomwise Business Overview

7.6.3 Atomwise AI Drug Development Introduction

7.6.4 Atomwise Revenue in AI Drug Development Business (2020-2025)

7.6.5 Atomwise Recent Development

7.7 Biovista Inc.

7.7.1 Biovista Inc. Company Details

7.7.2 Biovista Inc. Business Overview

7.7.3 Biovista Inc. AI Drug Development Introduction

7.7.4 Biovista Inc. Revenue in AI Drug Development Business (2020-2025)

7.7.5 Biovista Inc. Recent Development

7.8 Breg，Inc.

7.8.1 Breg，Inc. Company Details

7.8.2 Breg，Inc. Business Overview

7.8.3 Breg，Inc. AI Drug Development Introduction

7.8.4 Breg，Inc. Revenue in AI Drug Development Business (2020-2025)

7.8.5 Breg，Inc. Recent Development

7.9 Numerate

7.9.1 Numerate Company Details

7.9.2 Numerate Business Overview

7.9.3 Numerate AI Drug Development Introduction

7.9.4 Numerate Revenue in AI Drug Development Business (2020-2025)

7.9.5 Numerate Recent Development

7.10 Cloud Pharmaceuticals

7.10.1 Cloud Pharmaceuticals Company Details

7.10.2 Cloud Pharmaceuticals Business Overview

7.10.3 Cloud Pharmaceuticals AI Drug Development Introduction

7.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2020-2025)

7.10.5 Cloud Pharmaceuticals Recent Development

7.11 IBM

7.11.1 IBM Company Details

7.11.2 IBM Business Overview

7.11.3 IBM AI Drug Development Introduction

7.11.4 IBM Revenue in AI Drug Development Business (2020-2025)

7.11.5 IBM Recent Development

7.12 NuMedii

7.12.1 NuMedii Company Details

7.12.2 NuMedii Business Overview

7.12.3 NuMedii AI Drug Development Introduction

7.12.4 NuMedii Revenue in AI Drug Development Business (2020-2025)

7.12.5 NuMedii Recent Development

7.13 BenevolentAI

7.13.1 BenevolentAI Company Details

7.13.2 BenevolentAI Business Overview

7.13.3 BenevolentAI AI Drug Development Introduction

7.13.4 BenevolentAI Revenue in AI Drug Development Business (2020-2025)

7.13.5 BenevolentAI Recent Development

7.14 Lam Therapeutics

7.14.1 Lam Therapeutics Company Details

7.14.2 Lam Therapeutics Business Overview

7.14.3 Lam Therapeutics AI Drug Development Introduction

7.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2020-2025)

7.14.5 Lam Therapeutics Recent Development

8 AI Drug Development Market Dynamics

8.1 AI Drug Development Industry Trends

8.2 AI Drug Development Market Drivers

8.3 AI Drug Development Market Challenges

8.4 AI Drug Development Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global AI Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global AI Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market AI Drug Development Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global AI Drug Development Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global AI Drug Development Revenue Share by Region (2020-2025)

Table 6. Global AI Drug Development Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global AI Drug Development Revenue Share Forecast by Region (2026-2031)

Table 8. Global AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global AI Drug Development Revenue Market Share by Type (2020-2025)

Table 10. Global AI Drug Development Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global AI Drug Development Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global AI Drug Development Revenue Market Share by Application (2020-2025)

Table 15. Global AI Drug Development Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global AI Drug Development Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in AI Drug Development Application

Table 18. Global AI Drug Development Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global AI Drug Development Market Share by Players (2020-2025)

Table 20. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)

Table 21. Ranking of Global Top AI Drug Development Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by AI Drug Development Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of AI Drug Development, Headquarters and Area Served

Table 24. Global Key Players of AI Drug Development, Product and Application

Table 25. Global Key Players of AI Drug Development, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America AI Drug Development Revenue Market Share by Company (2020-2025)

Table 29. North America AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe AI Drug Development Revenue Market Share by Company (2020-2025)

Table 33. Europe AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 35. China AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 36. China AI Drug Development Revenue Market Share by Company (2020-2025)

Table 37. China AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 38. China AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan AI Drug Development Revenue Market Share by Company (2020-2025)

Table 41. Japan AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia AI Drug Development Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 47. India AI Drug Development Revenue by Company (2020-2025) & (US$ Million)

Table 48. India AI Drug Development Revenue Market Share by Company (2020-2025)

Table 49. India AI Drug Development Market Size by Type (2020-2025) & (US$ Million)

Table 50. India AI Drug Development Market Size by Application (2020-2025) & (US$ Million)

Table 51. Insilico Medicine Company Details

Table 52. Insilico Medicine Business Overview

Table 53. Insilico Medicine AI Drug Development Product

Table 54. Insilico Medicine Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 55. Insilico Medicine Recent Development

Table 56. Cyclica Company Details

Table 57. Cyclica Business Overview

Table 58. Cyclica AI Drug Development Product

Table 59. Cyclica Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 60. Cyclica Recent Development

Table 61. XtalPi Inc. Company Details

Table 62. XtalPi Inc. Business Overview

Table 63. XtalPi Inc. AI Drug Development Product

Table 64. XtalPi Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 65. XtalPi Inc. Recent Development

Table 66. Exscientia Limited Company Details

Table 67. Exscientia Limited Business Overview

Table 68. Exscientia Limited AI Drug Development Product

Table 69. Exscientia Limited Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 70. Exscientia Limited Recent Development

Table 71. AiCure, LLC Company Details

Table 72. AiCure, LLC Business Overview

Table 73. AiCure, LLC AI Drug Development Product

Table 74. AiCure, LLC Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 75. AiCure, LLC Recent Development

Table 76. Atomwise Company Details

Table 77. Atomwise Business Overview

Table 78. Atomwise AI Drug Development Product

Table 79. Atomwise Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 80. Atomwise Recent Development

Table 81. Biovista Inc. Company Details

Table 82. Biovista Inc. Business Overview

Table 83. Biovista Inc. AI Drug Development Product

Table 84. Biovista Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 85. Biovista Inc. Recent Development

Table 86. Breg，Inc. Company Details

Table 87. Breg，Inc. Business Overview

Table 88. Breg，Inc. AI Drug Development Product

Table 89. Breg，Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 90. Breg，Inc. Recent Development

Table 91. Numerate Company Details

Table 92. Numerate Business Overview

Table 93. Numerate AI Drug Development Product

Table 94. Numerate Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 95. Numerate Recent Development

Table 96. Cloud Pharmaceuticals Company Details

Table 97. Cloud Pharmaceuticals Business Overview

Table 98. Cloud Pharmaceuticals AI Drug Development Product

Table 99. Cloud Pharmaceuticals Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 100. Cloud Pharmaceuticals Recent Development

Table 101. IBM Company Details

Table 102. IBM Business Overview

Table 103. IBM AI Drug Development Product

Table 104. IBM Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 105. IBM Recent Development

Table 106. NuMedii Company Details

Table 107. NuMedii Business Overview

Table 108. NuMedii AI Drug Development Product

Table 109. NuMedii Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 110. NuMedii Recent Development

Table 111. BenevolentAI Company Details

Table 112. BenevolentAI Business Overview

Table 113. BenevolentAI AI Drug Development Product

Table 114. BenevolentAI Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 115. BenevolentAI Recent Development

Table 116. Lam Therapeutics Company Details

Table 117. Lam Therapeutics Business Overview

Table 118. Lam Therapeutics AI Drug Development Product

Table 119. Lam Therapeutics Revenue in AI Drug Development Business (2020-2025) & (US$ Million)

Table 120. Lam Therapeutics Recent Development

Table 121. AI Drug Development Market Trends

Table 122. AI Drug Development Market Drivers

Table 123. AI Drug Development Market Challenges

Table 124. AI Drug Development Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. AI Drug Development Product Picture

Figure 2. Global AI Drug Development Market Share by Type: 2024 VS 2031

Figure 3. Drug Design Features

Figure 4. Drug Synthesis Features

Figure 5. Other Features

Figure 6. Global AI Drug Development Market Share by Application: 2024 VS 2031

Figure 7. Tumor

Figure 8. Nervous System

Figure 9. Other

Figure 10. AI Drug Development Report Years Considered

Figure 11. Global AI Drug Development Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global AI Drug Development Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global AI Drug Development Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. China AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Japan AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Southeast Asia AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. India AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Central & South America AI Drug Development Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Global AI Drug Development Market Share by Players in 2024

Figure 22. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by AI Drug Development Revenue in 2024

Figure 24. North America AI Drug Development Market Share by Type (2020-2025)

Figure 25. North America AI Drug Development Market Share by Application (2020-2025)

Figure 26. Europe AI Drug Development Market Share by Type (2020-2025)

Figure 27. Europe AI Drug Development Market Share by Application (2020-2025)

Figure 28. China AI Drug Development Market Share by Type (2020-2025)

Figure 29. China AI Drug Development Market Share by Application (2020-2025)

Figure 30. Japan AI Drug Development Market Share by Type (2020-2025)

Figure 31. Japan AI Drug Development Market Share by Application (2020-2025)

Figure 32. Southeast Asia AI Drug Development Market Share by Type (2020-2025)

Figure 33. Southeast Asia AI Drug Development Market Share by Application (2020-2025)

Figure 34. India AI Drug Development Market Share by Type (2020-2025)

Figure 35. India AI Drug Development Market Share by Application (2020-2025)

Figure 36. Insilico Medicine Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 37. Cyclica Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 38. XtalPi Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 39. Exscientia Limited Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 40. AiCure, LLC Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 41. Atomwise Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 42. Biovista Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 43. Breg，Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 44. Numerate Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 45. Cloud Pharmaceuticals Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 46. IBM Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 47. NuMedii Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 48. BenevolentAI Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 49. Lam Therapeutics Revenue Growth Rate in AI Drug Development Business (2020-2025)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Drug Development market? zhanKai

The top companies in the global AI Drug Development market are Insilico Medicine、Cyclica、XtalPi Inc..

Related Reports

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 112
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 114
USD 2900.00
(Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 141
USD 4900.00
(Single User License)
AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Drug Development was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 119
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 81
USD 2900.00
(Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published Date: 2024-04-08
Pages: 111
USD 4900.00
(Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 114
USD 3950.00
(Single User License)
Global AI Drug Development Market Research Report 2024
The global AI Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)

AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Development was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 112
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2026
The global AI Drug Development market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 114
USD 2900.00 (Single User License)
Global AI Drug Development Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Development market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 141
USD 4900.00 (Single User License)
AI Drug Development- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Drug Development was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 119
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2025
The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 81
USD 2900.00 (Single User License)
Global AI Drug Development Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI Drug Development Market
Published: 2024-04-08
Pages: 111
USD 4900.00 (Single User License)
AI Drug Development - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Development was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 114
USD 3950.00 (Single User License)
Global AI Drug Development Market Research Report 2024
The global AI Drug Development market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 87
USD 2900.00 (Single User License)